ReviewFrontiers in oncology2022

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer.

Joanna Moes-Sosnowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.